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The presence of cytochrome P-450 and associated mono-oxygenase activities was examined in brain
microsomes from male and female mice. Although the cytochrome P-450 level in male mouse brain was very
low as compared with mouse liver, the aminopyrine N-demethylase and morphine N-demethylase specific
activities in male mouse brain were much higher than those observed in mouse liver. Ethoxycoumarin
O-de-ethylase and aniline hydroxylase activities were, however, not detected in mouse brain. Sex-related
differences were observed in both the cytochrome P-450 levels and aminopyrine N-demethylase activity in
mouse brain, the levels of both being higher in male mouse brain as compared with female mouse brain.
Aminopyrine N-demethylase activity in mouse brain microsomes was dependent on the presence of oxygen
and NADPH and could be inhibited by piperonyl butoxide, N-octyl imidazole and carbon monoxide.
Antiserum raised to the phenobarbital-inducible form of rat liver cytochrome P-450 [P-450(b+e)] inhibited
mouse brain aminopyrine N-demethylase activity by around 80 %. Mouse brain microsomal protein
exhibited cross-reactivity against this antiserum when examined by Ouchterlony double diffusion and
immunoblotting. The present results indicate the presence of a phenobarbital-inducible form of cytochrome
P-450 (or a form of cytochrome P-450 that is similar immunologically) in mouse brain microsomes, which
is associated with a sex-related difference.
INTRODUCTION
Cytochrome P-450 (referred to as 'P-450') and asso-
ciated mono-oxygenase activities play an important role
in the metabolism of endogenous compounds and xeno-
biotics. Although the liver is the primary organ involved
in the metabolism of foreign compounds, recent interest
has centred upon the capability of extra-hepatic organs
to metabolize xenobiotics (Gram et al., 1986). The
presence of P-450 in the brain could play an important
role in the pharmacokinetic modulation of psychoactive
drugs in the central nervous system. Further, since the
brain has limited regenerative capability, bioactivation
of xenobiotics to reactive metabolites by cerebral P-450
may be particularly hazardous. Studies on the properties
of cerebral P-450 have been scanty due to the instability
of the cerebral P-450, very low levels of detectable
activity and the contamination of the microsomal frac-
tions with haemoglobin (Mensil et al., 1984).
In rat brain, P-450 and associated mono-oxygenases
have been detected in low amounts compared with levels
in rat liver (Sasame et al., 1977; Marietta et al., 1979;
Guengerich & Mason, 1979; Das et al., 1981; Srivatsava
et al., 1983; Mensil et al., 1985; Walther et al., 1986).
However, in all the above studies, the detectable
mono-oxygenase activity was much lower than that
observed in the liver. Mouse brain microsomes were
reported to contain even lower amounts of P-450 than
rat brain (Nabeshima et al., 1981).
In the present study, P-450-linked mono-oxygenases
were estimated in brain microsomes from male and
female mice, and compared with the respective hepatic
levels. We report the presence of a high concentration of
aminopyrine N-demethylase activity in mouse brain and
an associated sex-related difference. The immunological
similarity of the mouse brain P-450 with the pheno-
barbital-inducible form of rat liver P-450 [P-450(b+e)] is
also described.
MATERIALS AND METHODS
Male and female Swiss Albino mice (3 months old),
obtained from the stock colony of the Institute, were
used in all the experiments. Animals had access to pelleted
diet (Hindustan Lever Ltd., Bombay, India) and water
ad libitum. Prior to decapitation, animals were anaes-
thetized with ether and their brains were perfused via the
left ventricle with Tris-buffered saline (10 ml). Brains
were quickly removed, rinsed in perfusion buffer, blotted
and weighed. The tissue was then homogenized in 10 vol.
of 0.1 M-Tris containing 0.1 mM-dithiothreitol, 0.1 mM-
phenylmethanesulphonyl fluoride, 0.2 mM-EDTA, 1.15
(w/v) potassium chloride and 20 o (v/v) glycerol
(pH 7.4). The homogenate was centrifuged at 17000 g in
a refrigerated centrifuge (4 °C) for 30 min. The super-
natant was decanted and the pellet was homogenized in
5 vol. of the Tris/glycerol buffer and centrifuged again at
17000 g for 30 min. The supernatants were pooled and
centrifuged at 100000 g (4 °C) for I h. The pellet was
resuspended in the buffer, homogenized gently and
centrifuged at 100000 g (4 °C) for I h. The washed pellet
was suspended in a small volume of Tris/glycerol buffer,
aliquoted, stored in liquid N2 and used within 1 week of
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preparation. Microsomes were prepared from brains
from 20 mice, pooled for each experiment. Livers were
also perfused during transcardial perfusion. The right
central lobes of the livers were also removed, pooled and
used for the preparation of microsomes. The purity of
the brain microsomal fraction was examined by electron
microscopy, and the 100000 g pellet was found to be
highly enriched with microsomal vesicles and contained
less than 30 contamination with mitochondria. Assay
of monoamine oxidase activity (Krajl, 1965) in mouse
brain microsomes revealed the activity to be only 0.26%
of that present in the mitochondrial fraction. Mito-
chondrial activity was 3.54 nmol/min per mg of protein.
Cytochrome P-450 levels were measured by the method
of Matsubara (Matsubara et al., 1976). NADPH-cyto-
chrome c reductase (Phillips & Langdon, 1962), aniline
hydroxylase (Imai et al., 1966), 7-ethoxycoumarin O-de-
ethylase (Greenlee & Poland, 1978) and total protein
using bovine serum albumin (Fraction V, Sigma Chemi-
cal Co.) as standard (Bradford, 1976) were measured as
described. Aminopyrine N-demethylase and morphine
N-demethylase activities were estimated according to the
procedure of Werringloer (1978). Incubations were car-
ried out in 0.05 M-Tris buffer (pH 7.5) containing 20 mM-
magnesium chloride, 1.8 mM-aminopyrine and 10,tg of
microsomal protein in a total volume of 1 ml. After
preincubation for 3 min at 37 °C, the reaction was
initiated by the addition of NADPH to a final concen-
tration of 3.1 mm. After 10 min of incubation at 37 °C,
the reaction was stopped by addition of 0.5 ml of 100
(w/v) trichloroacetic acid. The formaldehyde formed
was estimated in the supernatant following centrifug-
ation, using NASH reagent as described (Werringloer,
1978). Blank tubes containing boiled microsomes, no
substrate or no NADPH were run simultaneously and
these blank values, which were similar in all cases, were
subtracted from the experimental values. All analyses
were performed in duplicate for each batch ofmicrosomes
and values given are means of at least three experiments.
In experiments with inhibitors of P-450, blanks con-
taining inhibitors but no NADPH were also run.
Hepatic P-450 was purified from phenobarbital-pre-
treated rats to apparent homogeneity (Guengerich &
Martin, 1980). The specific content was 13 nmol of
P-450/mg of protein. Antibodies were raised to P-450
(Kamataki et al., 1976) in rabbits, and antiserum was
collected and stored at -70 'C. Ouchterlony double
diffusion was performed on agar-coated plates as de-
scribed (Ouchterlony, 1962). There was a clear immuno-
precipitation band between purified P-450 from
phenobarbital-pretreated rat liver and the antiserum
raised to P-450. No precipitin bands were observed with
preimmune serum. Ouchterlony double diffusion was
performed using mouse brain microsomes and the anti-
serum to P-450. The assay of mouse brain microsomal
mono-oxygenase activity was carried out in the presence
of antiserum raised to P-450 in certain experiments. In
these experiments, control tubes contained equal quanti-
ties of preimmune serum. Microsomes were preincubated
with sera (both preimmune and immune) for 30 min at
37 'C prior to carrying out the assay. SDS/poly-
acrylamide-gel electrophoresis of microsomal proteins
was carried out as described (Laemmli, 1970). Proteins
were transferred from the gel to nitrocellulose sheets
using the procedure of Towbin et al. (1979). A current
setting of 200 mA was used for the transfer. Subsequent
to the transfer, the proteins on the nitrocellulose sheets
were immunostained with antiserum to P-450 as de-
scribed (Guengerich et al., 1982).
RESULTS
The microsomal aminopyrine N-demethylase activity
in mouse brain and liver is given in Table 1. A sex-related
difference was observed; the male mouse brain had much
higher activity than the female mouse brain. No such
difference was observed in the liver. Further, the specific
activity of aminopyrine N-demethylase in male mouse
Table 1. Cytochrome P450-linked mono-oxygenases and NADPH-cytochrome c reductase in male and female mouse hepatic and
cerebral microsomes
Values are means+ S.D. of at least three separate experiments, with three different batches of microsomes.
Brain
Male
Liver
Female Male FemaleEnzyme
Aminopyrine N-demethylase
(nmol of formaldehyde formed/min per mg of protein)
Morphine N-demethylase
(nmol of formaldehyde/min per mg of protein)
7-Ethoxycoumarin O-de-ethylase
(nmol of 7-hydroxycoumarin formed/min per mg of protein)
Aniline hydroxylase
(nmol of p-aminophenol formed/min per mg of protein)
Cytochrome P-450
(nmol/mg of protein)
NADPH-cytochrome c reductase
(nmol of cytochrome c reduced/min per mg of protein)
173.75 + 5.00 91.25 + 3.75 97.5 + 10.00 98.75 + 8.75
40.52 + 3.95 41.29 + 2.99 23.37 + 1.89 21.40 + 3.07
ND*
NDt
ND*
NDt
0.043 + 0.01 0.016 + 0.005
23.79 +4.47 23.23 +4.97
7.33+ 1.12 6.51 + 1.70
32.11 + 1.34 29.52+0.55
0.92 + 0.06 0.90 + 0.04
78.84+8.91 90.43+26.12
* Minimal detectable activity was 0.05 nmol of product formed/min per mg of protein.
t Minimal detectable activity was 0.01 nmol of product formed/min per mg of protein.
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Fig. 1. Effects of (a) microsomal protein concentration, (b) incubation time and (c, d) substrate concentration on brain microsomal
aminopyrine N-demethylase activity
0, Male mouse brain activity; *, female mouse brain activity. Values are expressed as means+S.D. (n = 3, different batches
of microsomes). (a) Microsomal protein was incubated for 10 min; aminopyrine concentration was 1.8 mm. (b) Microsomal
incubations were carried out with 5 and 6,ug of male and female mouse brain microsomal protein respectively per ml.
Aminopyrine concentration was 1.8 mm. (c) Microsomal incubations were performed for 5 min. Protein concentrations were
S and 6 ,ug of male and female mouse brain microsomal protein respectively per ml. v represents the velocity, expressed as
nmol of formaldehyde formed/min per mg of protein, and S represents aminopyrine concentrations in mm. (d) Eadie-Hofstee
plot of data from (c). Km values for male and female brain aminopyrine N-demethylase were 0.49 mm and 0.52 mm, respectively
and Vmax values were 215 and 120 nmol of formaldehyde formed/min per mg of protein respectively.
brain was much higher than that observed in liver. A
similar sex difference was also observed in total cerebral
P-450, which in the male brain was only 4.60% of the
hepatic level. Ethoxycoumarin O-de-ethylase and aniline
hydroxylase activities were not detectable in cerebral
microsomes, although they were detectable in the liver.
In both male and female mouse brain, the activity of
morphine N-demethylase was higher than that observed
in liver; but no sex-related differences were detected. The
level of NADPH-cytochrome c reductase in mouse brain
was 27 of that present in liver (Table 1).
The effect of protein concentration on male and female
brain microsomal aminopyrine N-demethylase activity is
shown in Fig. l(a). The enzyme activity was linear up to
a protein concentration of 10 jug/ml of incubation
medium. The enzyme activity was also linear up to 10 min
of incubation time, and did not increase thereafter (Fig.
lb). The dependence of the enzyme activity on substrate
concentration is shown in Fig. 1(c) and the Eadie-Hofstee
plot of these data is depicted in Fig. 1(d). The Vmax of
aminopyrine N-demethylase activity was calculated as
215 and 120 nmol of product formed/min per mg of
protein in male and female mouse brain microsomes
respectively. The respective Km values were 0.49 and
0.52 mm, as calculated from the Eadie-Hofstee plot (Fig.
ld). The sex-related difference in cerebral aminopyrine
N-demethylase activity was observed consistently.
Piperonyl butoxide at a concentration of 0.5 mM
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inhibited microsomal aminopyrine N-demethylase in
male mouse brain by 45 0. Addition of N-octyl imidazole
(1 mM), another inhibitor of P-450, resulted in 5000
inhibition of aminopyrine N-demethylase. When incub-
ations were carried out in an atmosphere of 100
carbon monoxide, a greater loss of activity (82 %) was
observed (Table 2). The enzyme activity was dependent
Table 2. Effect of inhibitors on aminopyrine N-demethylase
activity in male mouse brain microsomes
All incubations were carried out at 37 'C. Control incu-
bations were carried out in an atmosphere of air, blanks
containing no substrate or no NADPH were run and their
values subtracted from experimental values. The control
value for male mouse brain aminopyrine N-demethylase
activity was 177.7 + 8.2 nmol of formaldehyde formed/min
per mg of protein. Values are means + S.D. of three analyses
on the same batch of microsomes.
Treatment
Control
10000 02
100% CO
100% N2
N-Octyl imidazole (1 mM)
Piperonyl butoxide (0.5 mM)
Activity
(%o of control)
100
136.50+ 6.12
17.60+9.14
36.28 + 12.03
50.12 + 3.50
54.70 + 2.50
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Fig. 2. Inhibition of mouse brain (a) aminopyrine N-demethylase
phenobarbital-inducible form of rat liver P450
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and (b) morphine N-demethylase activity by antiserum to a
Microsomes were preincubated with preimmune (A) or immune (0) serum for 30 min at 37 °C prior to addition of substrate
and NADPH. Microsomal incubations contained 5 /tg of protein/ml and were incubated with substrate for 10 min. Values are
means+ S.D. from three analyses on same batch of microsomes.
on the presence of oxygen and NADPH; a marked
enhancement in activity occurred when incubations were
carried out in a 1000% oxygen atmosphere.
Addition of antiserum to phenobarbital-inducible rat
liver P-450 inhibited mouse brain aminopyrine N-
demethylase in a dose-dependent manner, maximal in-
hibition being 800 (Fig. 2a). No inhibition was observed
when pre-immune serum was added. Morphine N-
demethylase was inhibited to a lesser extent (45 0%) by the
same antiserum (Fig. 2b). Ouchterlony double diffusion
of mouse brain microsomes and antiserum to rat liver
phenobarbital-inducible P-450 showed a clear immuno-
precipitin line (Fig. 3). No precipitin lines were observed
with preimmune serum. SDS/polyacrylamide-gel electro-
phoresis of mouse brain microsomes revealed several
protein bands of approx. Mr 50000 after Coomassie
Blue staining (results not shown). Following SDS/
polyacrylamide-gel electrophoresis, the proteins were
transferred electrophoretically to nitrocellulose mem-
branes and immunostained with antiserum to pheno-
barbital-inducible rat liver P-450. A single protein band
(corresponding to a similar band in mouse liver micro-
somes) was revealed by the antiserum in both male and
female brain microsomes (Figs. 4a and 4b), which co-
migrated with purified P-450(b+,.
DISCUSSION
The specific activities of aminopyrine N-demethylase
and morphine N-demethylase in male mouse brain were
(a)
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Fig. 3. Ouchterlony immunodiffusion of male mouse brain
microsomes and antiserum to phenobarbital-inducible rat
liver P450
The central well contained 86 ,tg of microsomal protein
and the outer wells contained antiserum diluted in the
following concentrations: 1, undiluted; 2, 2 times; 3, 4
times; 4, 8 times; 5, 16 times; 6, 32 times. The gel was
incubated at 4°C for 48 h, washed and stained with
Coomassie Blue.
Fig. 4. Immunoblots of purified cytochrome P450(b+e) and mouse
brain and liver microsomes after staining with antiserum
to phenobarbital-inducible rat liver P450
(a) Lane 1, purified P-450(b+e) antigen (5 pg/lane); lane 2,
male brain microsomes (38 jug/lane). (b) Lane 1, marker
protein (Mr 66000); lane 2, male liver microsomes (32 ,ug/
lane); lane 3, male brain microsomes (43 ,g/lane);
lane 4, female liver microsomes (33 pg/lane); lane 5, female
brain microsomes (47 ,ug/lane).
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higher than those observed in the mouse liver. However,
ethoxycoumarin O-de-ethylase and aniline hydroxylase
activities were not detectable in mouse brain microsomes,
indicating that certain isoenzymes of P-450 probably
predominate in mouse brain. Further, the presence of
high specific activities of aminopyrine and morphine N-
demethylase in mouse brain indicates that the brain may
possess considerable metabolizing capability against
certain substrates. Distinct sex-related differences were
observed in aminopyrine N-demethylase activity, which
could be immunochemically inhibited by the antibody to
phenobarbital-inducible P-450. In rat liver, similar sex-
related differences are known in phenobarbital-inducible
P-450 and associated mono-oxygenase activities (Kato &
Gillette, 1965; Kato & Onada, 1970; Thomas et al.,
1981). More recently it has been demonstrated that sex-
related differences exist in the constitutive forms of
P-450b and PA450e in rat liver, and these differences
are enhanced following administration of phenobarbital
(Yamazoe et al., 1987). The phenobarbital-inducible
P-450h has very high N-demethylase activity towards
aminopyrine and benzphetamine (Guengerich, 1987);
aminopyrine is N-demethylated to a lesser extent by
other isoenzymes of P-450. Further, it has also been
demonstrated that pretreatment of mice with phenytoin
causes an induction of benzphetamine N-demethylase
activity in mouse brain and liver (Volk et al., 1988).
Thus, the immunochemical inhibition, Ouchterlony
double diffusion, and Western immunoblot data support
the presence of P-450(b+e) or a closely related form in
mouse brain. The presence of this form in mouse seems
to be linked with the sex-related difference.
Although the level of P-450 in the brain is much lower
than that in liver, certain associated mono-oxygenase
activities are very high in the brain. This indicates that
the brain may possess considerable xenobiotic metaboliz-
ing capability for certain substrates. This would have far-
reaching consequences, as exposure to environmental
toxins has been implicated in the pathogenesis of certain
degenerative neurological disorders (Calne et al., 1986).
The functional role of cerebral P-450 has not been well
understood. The sex difference observed in mouse brain
P-450 may serve as a useful model to evaluate the role
of P-450 in brain.
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